Skip to content
Search

Latest Stories

Well unveils initiative to asses risks to BAME staff

Well Pharmacy has joined forces with senior academic and pharmacist Professor Mahendra Patel to assess risks to its black Asian, and minority ethnic (BAME) staff.

The pharmacy chain also aims to explore how community pharmacy can improve healthcare services for the disadvantaged groups through the initiative.


The company said it is carrying out personal risk assessments for its teams following the recent NHS recommendations.

"With the BAME community highlighted in the NHS’ research as being at higher risk, we have sought Professor Patel’s insight to help make sure we approach this correctly so that we get the meaningful data we need through this process," said Jacqueline Lunardi, people director at Well.

Based at the University of Bradford, Professor Patel specialises in health inequalities associated with BAME and disadvantaged groups.

"Often, those in the BAME communities have a different outlook on healthcare," he commented.

“How you reach out and ask the right questions has to be carefully considered to make sure you get open and meaningful replies. I’d urge any company who is carrying out a risk assessment for their BAME colleagues to thoroughly consider their approach to make sure that this doesn’t just turn into a tick box exercise.”

Well hopes to involve its BAME staff members in the structure of the assessments, and any follow-up measures, to make sure that its employees are safe at their workplace during the Covid-19 pandemic.

The pharmacy group is also planning to enlist Professor Patel's support in ensuring culturally sensitive health messaging and improving the collection of better health information, within BAME and disadvantaged groups.

"We want to explore with Professor Patel what we can do differently and more effectively, and how we can reach out to those who may not be adequately receiving the health and wellbeing advice and support that’s available," commented Janice Perkins, pharmacy superintendent at Well.

"There may be many reasons for this, and we want to explore these and understand how we can help overcome them.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less